☆ 4.6 Article

Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer

BMC CANCER (2019)

Journal

BMC CANCER

Volume 19, Issue -, Pages -

Publisher

BMC

DOI: 10.1186/s12885-019-5320-2

Keywords

Breast cancer; Tumor-infiltrating lymphocytes; Tumor microenvironment; Neoadjuvant chemotherapy; Minimal residual disease; Disseminated tumor cells; T cells; B cells

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

BackgroundTumor-infiltrating lymphocytes (TILs) are described as an important immune modulator in the tumor microenvironment and are associated with breast cancer (BC) outcome. The spatial analysis of TILs and TIL subtype distribution at the invasive tumor front (ITF) and the tumor center (TC) might provide further insights into tumor progression.MethodsWe analyzed core biopsies from 87 pre-therapeutic BC patients for total TILs and the following subtypes: CD3+, CD4+, CD8+, CD20+ and CD68+ cells in correlation to clinicopathological parameters and disseminated tumor cells (DTCs) in the bone marrow.ResultsTILs and TIL subtypes showed significantly different spatial distribution among both tumor areas. TILs, especially CD3+ T cells were associated with the tumor status and tumor grading. BC patients responding to neoadjuvant chemotherapy had significantly more TILs and CD3+ T cells at the TC. The presence of DTCs after NACT was related to CD4+ infiltration at the TC.ConclusionThe dissimilar spatial association of TILs and TIL subtypes with clinicopathological parameters, NACT response and minimal residual disease underlines the necessity of detailed TIL analysis for a better understanding of immune modulatory processes.

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Genetics & Heredity

Correlation Between Immune-Related Genes and Tumor-Infiltrating Immune Cells With the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

Yan Zhou, Qi Tian, Huan Gao, Lizhe Zhu, Jiao Yang, Juan Zhang, Jin Yang

Summary: By analyzing gene expression and immune cells, this study found a correlation between immune-related genes and immune cells with the response to neoadjuvant chemotherapy in breast cancer, highlighting the significance of combining neoadjuvant chemotherapy with immunotherapy for better clinical benefits.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer

Kosuke Imamura, Yusuke Tomita, Ryo Sato, Tokunori Ikeda, Shinji Iyama, Takayuki Jodai, Misako Takahashi, Akira Takaki, Kimitaka Akaike, Shohei Hamada, Shinya Sakata, Koichi Saruwatari, Sho Saeki, Koei Ikeda, Makoto Suzuki, Takuro Sakagami

Summary: This study found that the infiltration of drebrin-expressing T cells within the tumor cell nest in resectable squamous cell lung cancer patients is associated with short relapse-free survival and overall survival. The in vitro induced drebrin(+) T cells co-express multiple exhaustion-associated molecules. Single-cell RNA-sequencing analysis confirmed that exhausted tumor-infiltrating CD8(+) T cells specifically expressed drebrin.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Tumor-Associated Lymphatics Upregulate MHC-II to Suppress Tumor-Infiltrating Lymphocytes

Claire Y. Li, Hyeung Ju Park, Jinyeon Shin, Jung Eun Baik, Babak J. Mehrara, Raghu P. Kataru

Summary: This study suggests that lymphatic endothelial cells (LECs) can act as immunosuppressive cells in the tumor microenvironment (TME) in an MHC-II dependent manner. LECs in the TME increase MHC-II expression and co-inhibitory signals, suppressing the immune response. This finding highlights the importance of understanding the role of LECs in tumor immunity and opens up new avenues for therapeutic interventions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Oncology

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression

Veronica Finisguerra, Tereza Dvorakova, Matteo Formenti, Pierre Van Meerbeeck, Lionel Mignion, Bernard Gallez, Benoit J. van den Eynde

Summary: Despite limitations in certain tumor types and patients, immunotherapies have achieved revolutionary success in cancer treatment. However, the efficacy of immunotherapies is dependent on the viability and functionality of tumor antigen-specific CD8 T cells within the immunosuppressive tumor microenvironment, where oxygen levels are often low. This study reveals that the antidiabetic drug metformin can improve CD8 T cell fitness in hypoxia, increasing their proliferation and cytokine production, and enhancing their infiltration and survival in hypoxic tumor areas. This presents a promising strategy to overcome resistance to immunotherapy in hypoxic and immunosuppressive tumors.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Add to Collection

Article Oncology

Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient age

Koji Takada, Shinichiro Kashiwagi, Yuka Asano, Wataru Goto, Tamami Morisaki, Masatsune Shibutani, Hiroaki Tanaka, Kosei Hirakawa, Masaichi Ohira

Summary: The study found that younger breast cancer patients have significantly higher TIL density than older patients, with differences in different molecular subtypes and higher complete pathological response rates in younger patients.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment

Iman M. M. Talaat, Noha M. M. Elemam, Shroque Zaher, Maha Saber-Ayad

Summary: Colorectal cancer is a prevalent cancer type worldwide, and the immune cells within the tumor microenvironment play a crucial role in its initiation and progression. Immune checkpoint molecules are highlighted as potential targets for immunotherapy in colorectal cancer.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Oncology

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Jesse Lopes da Silva, Lucas Zanetti de Albuquerque, Fabiana Resende Rodrigues, Guilherme Gomes de Mesquita, Priscila Valverde Fernandes, Luiz Claudio Santos Thuler, Andreia Cristina de Melo

Summary: This study found that the immune cell subtype in the tumor microenvironment after neoadjuvant chemotherapy can be a determining factor in the prognosis of patients with triple-negative breast cancer.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Tumor-infiltrating lymphocytes in patients undergoing esophagectomy following neoadjuvant DCF therapy

Keita Takahashi, Yuki Sakashita, Mutsunori Murahashi, Hoshiho Kubota, Masayuki Shimoda, Yoshitaka Ishikawa, Yuichiro Tanishima, Takanori Kurogochi, Fumiaki Yano, Ken Eto

Summary: Low levels of TI CD8+ cells were found to be a significant prognostic factor for patients with ESCC undergoing neoadjuvant DCF therapy followed by esophagectomy.

JOURNAL OF SURGICAL ONCOLOGY (2023)

Add to Collection

Article Oncology

MDR1-EXPRESSING CD4+ T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE

Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Celine Rodriguez, Yenkel Grinberg-Bleyer, Guilhem Lalle, Lyvia Moudombi, Raphael Schneider, Cyril Degletagne, Isabelle Treilleux, Daniel J. Campbell, Severine Metzger, Thomas Duhen, Olivier Tredan, Christophe Caux, Christine Menetrier-Caux

Summary: This study investigated the expression, function, and regulation of MDR1 in CD4(+) T cells and its role in neoadjuvant chemotherapy in breast cancer. The results showed that MDR1 expression was associated with the enrichment of Th1.17 and Th17 cells and correlated positively with pathological response. This study has important clinical implications for adjusting chemotherapy regimens.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Add to Collection

Article Medicine, Research & Experimental

Tumor-infiltrating lymphocytes are functionally inactivated by CD90+stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesothelioma

Haitang Yang, Sabina Berezowska, Patrick Dorn, Philipp Zens, Peiru Chen, Ren-Wang Peng, Thomas M. Marti, Gregor J. Kocher, Ralph A. Schmid, Sean R. R. Hall

Summary: This study investigates the relationship between the tumor microenvironment (TME) and tumor-infiltrating lymphocytes (TILs) in malignant pleural mesothelioma (MPM). The results suggest that targeting the TME can potentially redirect the fate of TILs and restore anti-tumor immunity in MPM.

THERANOSTICS (2022)

Add to Collection

Article Oncology

Ki67 Index Changes and Tumor-Infiltrating Lymphocyte Levels Impact the Prognosis of Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

Yihua Wang, Beige Zong, Yu Yu, Yu Wang, Zhenrong Tang, Rui Chen, Man Huang, Shengchun Liu

Summary: The study showed that Ki67 index changes and RD TIL levels were associated with the prognosis of patients with primary TNBC after NAC, with low RD TIL levels having greater prognostic significance in the no Ki67 decrease group.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma

R. S. A. Goedegebuure, M. Harrasser, L. K. de Klerk, T. S. van Schooten, N. C. T. van Grieken, M. Eken, M. S. Grifhorst, N. Pocorni, E. S. Jordanova, M. I. van Berge Henegouwen, R. E. Pouw, H. M. W. Verheul, J. J. van der Vliet, H. W. M. van Laarhoven, V. L. J. L. Thijssen, A. J. Bass, T. D. De Gruijl, S. Derks

Summary: In-depth analysis revealed a close relationship between the levels and distribution of T cells and the response to neoadjuvant CRT in esophageal adenocarcinoma patients. The presence of memory T cells in peripheral blood T cells contributes to a complete pathological response to CRT.

ONCOIMMUNOLOGY (2021)

Add to Collection

Article Immunology

Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer

Ming Zheng, Yi-Ming Li, Zhen-Yu Liu, Xin Zhang, Yinghui Zhou, Jian-Li Jiang, Ping Zhu, Xiang-Min Yang, Juan Tang, Zhi-Nan Chen

Summary: Immunotherapy targeting tumor-infiltrating lymphocytes has shown promising potential as a treatment for various cancers, but its efficacy varies across different cancer types and patients. The distribution of TIL-T and TIL-B cells and their interactions with the tumor microenvironment play a crucial role in determining the clinical outcomes. Understanding the prognostic significance of these factors can have important implications for cancer immunotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Health Care Sciences & Services

PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells

Bogdan Marian Caraban, Elena Matei, Georgeta Camelia Cozaru, Mariana Aschie, Mariana Deacu, Manuela Enciu, Gabriela Izabela Baltatescu, Anca Chisoi, Nicolae Dobrin, Lucian Petcu, Emma Gheorghe, Laurentiu-Tony Hangan, Mihai Catalin Rosu, Cristian Ionut Orasanu, Antonela-Anca Nicolau

Summary: This study aimed to characterize the PD-L1 expression in melanomas and its association with T cell infiltrates. The results showed that most of the PD-L1 positive tumors had moderate scores of CD4+ and CD8+ TILs in tumoral melanoma cells. PD-L1 expression was associated with different degrees of lymphocytic infiltration and with Breslow tumor thickness. PD-L1 expression is a predictive biomarker for discriminating the presence or absence of malign tumoral melanoma cells and an independent predictor of good prognosis in melanoma patients.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Add to Collection

Article Oncology

Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma

Ioana Plesca, Iva Benesova, Carolin Beer, Ulrich Sommer, Luise Mueller, Rebekka Wehner, Max Heiduk, Daniela Aust, Gustavo Baretton, Michael P. Bachmann, Anja Feldmann, Juergen Weitz, Lena Seifert, Adrian M. Seifert, Marc Schmitz

Summary: Tumor-infiltrating dendritic cells (DCs) are associated with survival of pancreatic ductal adenocarcinoma (PDAC) patients. Specifically, a higher frequency of cDC1s infiltration in the whole tumor area and tumor stroma, as well as an increased frequency of cDC2s infiltration in the intraepithelial tumor, is associated with improved survival.

CANCERS (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients

Nils Martin Bruckmann, Julian Kirchner, Lale Umutlu, Wolfgang Peter Fendler, Robert Seifert, Ken Herrmann, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Christina Antke, Lars Schimmoeller, Marc Ingenwerth, Katharina Breuckmann, Andreas Stang, Christian Buchbender, Gerald Antoch, Lino M. Sawicki

Summary: This study compared the diagnostic performance of different imaging techniques in detecting bone metastases in patients with primary breast cancer. [F-18]FDG PET/MRI and MRI alone showed significantly higher sensitivity and specificity than CT and bone scintigraphy; CT and bone scintigraphy had lower sensitivity in detecting bone metastases and were prone to false-positive results.

EUROPEAN RADIOLOGY (2021)

Add to Collection

Article Oncology

The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant Chemotherapy

Alexandra Edimiris-Herrmann, Cornelia Kolberg-Liedtke, Ann-Kathrin Bittner, Oliver Hoffmann, Sarah Wetzig, Mohamed Shaheen, Miltiades Stephanou, Hans-Christian Kolberg

Summary: The study found that C-reactive protein (CRP) levels before neoadjuvant chemotherapy (NACT) in patients with early breast cancer (EBC) were not associated with pathologic complete remission (pCR). However, higher baseline CRP levels showed a strong trend towards shorter overall survival (OS), disease-free survival (DFS), local recurrence-free survival (LRFS), and distant DFS (DDFS). There was a significant association between CRP levels and breast cancer mortality, with higher CRP levels indicating a higher risk of death. These findings suggest that CRP may serve as a biomarker for long-term prognosis in EBC and warrant further investigation.

BREAST CARE (2022)

Add to Collection

Article Immunology

Systematic Evaluation of HLA-G 3'Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients: UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease Outcome

Vera Rebmann, Esther Schwich, Rafael Tomoya Michita, Lisa Gruentkemeier, Ann-Kathrin Bittner, Hana Rohn, Peter A. Horn, Oliver Hoffmann, Rainer Kimmig, Sabine Kasimir-Bauer

Summary: This study systematically evaluated the impact of HLA-G 3'UTR polymorphisms on disease status, presence of DTC, soluble HLA-G levels, and therapy and disease outcome in non-metastatic LABC patients. The results showed that specific UTR haplotypes were associated with tumor burden, presence of DTC, and therapy and disease outcome.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in 18F-FDG PET/MRI

Nils Martin Bruckmann, Julian Kirchner, Janna Morawitz, Lale Umutlu, Wolfgang P. Fendler, Ken Herrmann, Ann-Kathrin Bittner, Oliver Hoffmann, Tanja Fehm, Maike E. Lindemann, Christian Buchbender, Gerald Antoch, Lino M. Sawicki

Summary: The study evaluated the ability of StarVIBE for detecting pulmonary nodules in F-18-FDG PET/MRI compared to CT. The results showed that CT had a significantly higher detection rate than MRI sequences, with StarVIBE having an advantage in detecting centrally located nodules.

EJNMMI PHYSICS (2022)

Add to Collection

Article Oncology

Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse

Oliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, Monika Collenburg, Peter A. Horn, Rainer Kimmig, Sabine Kasimir-Bauer, Vera Rebmann

Summary: This study evaluates extracellular vesicles and PD-L1/2-bearing extracellular vesicle subpopulations as potential surrogate markers for disease progression or eligibility criteria for PD-1 immune checkpoint inhibition in early TNBC. The study finds that high PD-L2(EV) levels are associated with reduced 3-year progression-free and overall survival, and a loss of PD-L2(EV) is more prominent in patients achieving pathological complete response after chemotherapy.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

A Role of PET/MR in Breast Cancer?

Nils Martin Bruckmann, Janna Morawitz, Wolfgang P. Fendler, Eugen Ruckhaeberele, Ann-Kathrin Bittner, Frederik L. Giesel, Ken Herrmann, Gerald Antoch, Lale Umutlu, Julian Kirchner

Summary: PET/MRI is a promising imaging modality with diverse applications in the field of oncology, particularly for breast cancer assessment and treatment monitoring. It provides superior accuracy in detecting distant and bone metastases compared to conventional CT and bone scan, and can significantly influence treatment plans. Additionally, PET/MRI reduces patients' radiation exposure and serves as a comprehensive diagnostic tool for local and whole-body staging of breast cancer.

SEMINARS IN NUCLEAR MEDICINE (2022)

Add to Collection

Article Oncology

Multiparametric 18F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

Lale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, Janna Morawitz, Gerald Antoch, Saskia Ting, Ann-Kathrin Bittner, Oliver Hoffmann, Lena Haeberle, Eugen Ruckhaeberle, Onofrio Antonio Catalano, Michal Chodyla, Johannes Grueneisen, Harald H. Quick, Wolfgang P. Fendler, Christoph Rischpler, Ken Herrmann, Peter Gibbs, Katja Pinker

Summary: This study used F-18-FDG PET/MRI radiomics analysis to predict pathological complete response in breast cancer patients before neoadjuvant therapy, especially in patients with HR+/HER2- receptor status.

CANCERS (2022)

Add to Collection

Article Oncology

Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI-Clinically Relevant?

Kai Jannusch, Nils Martin Bruckmann, Charlotte Johanna Geuting, Janna Morawitz, Frederic Dietzel, Christoph Rischpler, Ken Herrmann, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Harald H. Quick, Lale Umutlu, Gerald Antoch, Julian Kirchner

Summary: Image-based primary staging is crucial for women with newly-diagnosed breast cancer to exclude distant metastases. However, the use of [F-18]FDG-PET/MRI as a radiation-saving tool may lead to missed lung nodules. The study aimed to evaluate the clinical relevance of missed lung nodules at initial staging in [F-18]FDG-PET/MRI compared to CT. The results showed that while all patients with clinically-relevant lung nodules were detected using [F-18]FDG-PET/MRI, there was a small proportion of missed nodules due to the lower sensitivity of MRI.

CANCERS (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine Learning

Janna Morawitz, Benjamin Sigl, Christian Rubbert, Nils-Martin Bruckmann, Frederic Dietzel, Lena J. Haeberle, Saskia Ting, Svjetlana Mohrmann, Eugen Ruckhaeberle, Ann-Kathrin Bittner, Oliver Hoffmann, Pascal Baltzer, Panagiotis Kapetas, Thomas Helbich, Paola Clauser, Wolfgang P. Fendler, Christoph Rischpler, Ken Herrmann, Benedikt M. Schaarschmidt, Andreas Stang, Lale Umutlu, Gerald Antoch, Julian Caspers, Julian Kirchner

Summary: Machine-learning prediction models based on MRI or PET/MRI imaging features can accurately determine nodal status in breast cancer patients, with similar diagnostic accuracy to experienced radiologists. By adjusting the threshold, invasive procedures can potentially be avoided in about 68.2% of patients.

JOURNAL OF NUCLEAR MEDICINE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy

Thomas Hager, Sabrina Borchert, Michael Wessolly, Alexander Mathilakathu, Elena Mairinger, Jens Kollmeier, Thomas Mairinger, Balazs Hegedus, Kristina Greimelmaier, Jeremias Wohlschlaeger, Ken Herrmann, Fabian Dominik Mairinger

Summary: Malignant pleural mesothelioma (MPM) is a deadly asbestos-related tumor with limited treatment options. This study examines the expression of two proteins, MSLN and CXCR4, in MPM tumor samples and their potential as targets for endo-radioligand therapy. The results show significant expression of these proteins in a majority of the samples, suggesting the possibility of using radioligand-based diagnostics and endo-radiotherapy for MPM patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Oncology

Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer

Kai Jannusch, Ann-Kathrin Bittner, Nils Martin Bruckmann, Janna Morawitz, Cleo Stieglitz, Frederic Dietzel, Harald H. Quick, Hideo A. Baba, Ken Herrmann, Lale Umutlu, Gerald Antoch, Julian Kirchner, Sabine Kasimir-Bauer, Oliver Hoffmann

Summary: Histological and molecular characteristics of breast cancer are crucial for personalized treatment and risk assessment. This study aimed to explore the correlation between PET/MRI imaging markers and invasive acquired biomarkers in newly diagnosed early breast cancer. The results showed that [F-18]FDG-PET/MRI can provide initial information on BC-receptor status and tumor biology, but cannot replace biopsy for distinguishing DTC-positive/-negative patients.

CANCERS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning Model

Sabrina Borchert, Alexander Mathilakathu, Alina Nath, Michael Wessolly, Elena Mairinger, Daniel Kreidt, Julia Steinborn, Robert F. H. Walter, Daniel C. Christoph, Jens Kollmeier, Jeremias Wohlschlaeger, Thomas Mairinger, Luka Brcic, Fabian D. Mairinger

Summary: The expression level of Fibroblast activation protein alpha (FAP) is associated with the formation of desmoplastic stromal reaction (DSR) in pleural mesothelioma (PM). DSR-high samples demonstrated a significant prolongation of median survival time, indicating the important role of cancer-associated fibroblasts (CAFs) in tumor prognosis. These findings provide a basis for introducing new therapeutic strategies and predictive biomarkers for survival in PM.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies

Susann Stephan-Falkenau, Anna Streubel, Thomas Mairinger, Torsten-Gerriet Blum, Jens Kollmeier, Fabian D. Mairinger, Torsten Bauer, Joachim Pfannschmidt, Manuel Hollmann, Michael Wessolly

Summary: Pulmonary sarcomatoid carcinoma (PSC) is a highly aggressive subtype of lung cancer with poor clinical outcomes. In this study, we characterized 179 PSC cases and identified clinical, immunological, and molecular features using various techniques. We found that PSC is more common in men, older individuals, and smokers. Surgery was associated with improved overall survival. PD-L1 expression was detected in the majority of patients, and altered epitopes due to processing mutations contributed to immune escape and decreased survival. Genomic alterations for which there are approved drugs were present in a subset of patients. MET exon 14 skipping was found to be more frequent compared to other non-small cell lung cancers. In conclusion, the unique genomic and immunological features of PSC should be considered in therapy stratification.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times

Kai Jannusch, Maike E. Lindemann, Nils Martin Bruckmann, Janna Morawitz, Frederic Dietzel, Kelsey L. Pomykala, Ken Herrmann, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Lale Umutlu, Gerald Antoch, Harald H. Quick, Julian Kirchner

Summary: Breast PET/MRI protocols can be shortened from 20 to below 10 minutes without losing essential diagnostic information.

EUROPEAN RADIOLOGY (2023)

Add to Collection

Article Obstetrics & Gynecology

Complications and satisfaction in transwomen receiving breast augmentation: short- and long-term outcomes

A. K. Schoffer, A. K. Bittner, J. Hess, R. Kimmig, O. Hoffmann

Summary: This retrospective study analyzed the outcomes of breast augmentation surgery in transgender women. The results showed that 5% of patients experienced complications requiring re-operations, and 3% developed capsular contracture. The majority of patients were satisfied with the outcomes and reported an improvement in their quality of life due to the surgery.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.